Dyne Therapeutics, Inc. Common Stock DYN
$20.31
-16.35%
at last close
Analyst Consensus
- Consensus Rating
- Buy (9 Buy · 2 Hold · 0 Sell)
- Average Price Target
- $35.56
- Implied Upside
- +75.1%
- Price Target Range
- $16.00 – $50.00
- Analysts (12 mo)
- 11
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-07-31 | Morgan StanleyMichael Ulz |
Maintains | Overweight | $47 → $45 |
| 2026-07-30 | RBC CapitalLuca Issi |
Maintains | Outperform | $30 → $35 |
| 2026-07-23 | Cantor FitzgeraldEric Schmidt |
Initiates coverage on | Overweight | — |
| 2026-06-26 | TD CowenJoseph Thome |
Initiates coverage on | Buy | — |
| 2026-05-15 | Evercore ISI GroupGavin Clark-Gartner |
Maintains | Outperform | $34 → $33 |
| 2026-05-13 | BernsteinWilliam Pickering |
Maintains | Market perform | $23 → $24 |
| 2026-03-09 | Chardan CapitalKeay Nakae |
Maintains | Buy | $38 |
| 2026-03-03 | Morgan StanleyMichael Ulz |
Maintains | Overweight | $50 → $47 |
| 2026-03-03 | Chardan CapitalKeay Nakae |
Maintains | Buy | $38 |
| 2026-03-03 | HC Wainwright & Co.Ananda Ghosh |
Maintains | Buy | $60 → $50 |
| 2026-01-20 | JP MorganTessa Romero |
Maintains | Neutral | $17 → $16 |
| 2025-12-15 | Evercore ISI GroupGavin Clark-Gartner |
Maintains | Outperform | $38 → $36 |
| 2025-12-11 | StifelPaul Matteis |
Maintains | Buy | $36 → $39 |
| 2025-12-10 | OppenheimerAndreas Argyrides |
Upgrades | Perform → Outperform | $11 → $40 |
| 2025-12-09 | Morgan StanleyMichael Ulz |
Maintains | Overweight | $46 → $50 |
| 2025-12-09 | Chardan CapitalKeay Nakae |
Maintains | Buy | $38 |
| 2025-12-08 | HC Wainwright & Co.Ananda Ghosh |
Maintains | Buy | $46 → $60 |
| 2025-11-14 | JP MorganTessa Romero |
Maintains | Neutral | $18 → $17 |
| 2025-11-12 | OppenheimerAndreas Argyrides |
Maintains | Perform | $13 → $11 |
| 2025-11-06 | HC Wainwright & Co.Ananda Ghosh |
Maintains | Buy | $38 → $46 |
| 2025-11-06 | RBC CapitalLuca Issi |
Maintains | Outperform | $23 → $30 |
| 2025-10-10 | OppenheimerAndreas Argyrides |
Downgrades | Outperform → Perform | $13 |
| 2025-08-25 | Raymond JamesMartin Auster |
Upgrades | Outperform → Strong buy | $31 → $35 |
| 2025-08-06 | OppenheimerAndreas Argyrides |
Maintains | Outperform | $34 → $13 |
| 2025-07-31 | StifelPaul Matteis |
Maintains | Buy | $66 → $36 |
| 2025-07-29 | RBC CapitalLuca Issi |
Maintains | Outperform | $25 → $23 |
| 2025-07-29 | Raymond JamesMartin Auster |
Reiterates | Outperform | $37 → $31 |
| 2025-07-29 | Chardan CapitalKeay Nakae |
Maintains | Buy | $50 → $38 |
| 2025-07-15 | JP MorganTessa Romero |
Maintains | Neutral | $10 → $9 |
| 2025-06-26 | Jones TradingCatherine Novack |
Initiates coverage on | Buy | $30 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $20.31
- Market Cap
- $3.79 billion
- 52-Week Range
- $9.89 – $27.30
- Average Volume
- 2.32 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.